Enduring Material CME: Diabetes CME: Breaking News on Incretin-Based Therapies Summary Conference Report: International Medical Press: June 26, 2008 - June 26, 2009
http://www.cmenetworks.com/cme/9874/1/Enduring-Material-CME-Diabetes-CME-Breaking-News-on-Incretin-Based-Therapies-Summary-Conference-Report-International-Medical-Press--June-26-2008----June-26-2009/Page1.html
International Medical Press
International Medical Press (IMP) is a provider of independent continuing medical education with a 20-year history of delivering multi-format and multidisciplinary education. With a considerable breadth and depth of therapeutic expertise in the areas of diabetes, cardiometabolic risk, critical care, infectious diseases, and osteoporosis. IMP produces accurate, clinically relevant , unbiased content guaranteed through extensive content review processes. IMP’s continuing education providers units are accredited by the ACCME, ANCC, and ACPE and our staff are recognized as experts in the CME enterprise.
By International Medical Press
Published on 09/29/2008
This activity is intended for endocrinologists, diabetologists, diabetes educators, nurses, and other healthcare professionals (HCPs) who treat patients with T2D.
CME Sponsor:
Location:
This is a web-based enduring material CME
Registration Fees: Free
Number of Credits:
0.75 AMA PRA Category 1 Credit(s)™
0.75 contact hours (0.075 CEUs)
Link
Summary Conference Report
Detailed Description:
Breaking News on Incretin-Based Therapies: Summary Conference Report in Conjunction With the 2008 American Diabetes Association's 68th Annual Scientific Sessions is an educational activity designed to increase awareness and understanding of the role of incretin-based therapies in the treatment of patients with T2D. The report provides a practical overview of the most clinically relevant data on incretin-based therapies presented through posters and oral presentations at the 68th Scientific Sessions of the American Diabetes Association in San Francisco, June 6-10, 2008.
Learning Objectives:
Breaking News on Incretin-Based Therapies Summary Conference Report
This activity is intended for endocrinologists, diabetologists, diabetes educators, nurses, and other healthcare professionals (HCPs) who treat patients with T2D.
Breaking News on Incretin-Based Therapies Summary Conference Report
CME Sponsor:
International Medical Press
Location:
This is a web-based enduring material CME
Registration Fees: Free
Number of Credits:
0.75 AMA PRA Category 1 Credit(s)™
0.75 contact hours (0.075 CEUs)
Link
Summary Conference Report
Detailed Description:
Breaking News on Incretin-Based Therapies: Summary Conference Report in Conjunction With the 2008 American Diabetes Association's 68th Annual Scientific Sessions is an educational activity designed to increase awareness and understanding of the role of incretin-based therapies in the treatment of patients with T2D. The report provides a practical overview of the most clinically relevant data on incretin-based therapies presented through posters and oral presentations at the 68th Scientific Sessions of the American Diabetes Association in San Francisco, June 6-10, 2008.
Learning Objectives:
- Summarize current data that describe the clinical efficacy and safety of DPP-4 inhibitors for the treatment of T2D
- Discuss current data that describe the clinical efficacy and safety of incretin mimetics for the treatment of T2D
- Discuss the appropriate clinical application of incretin-based therapies, including proper patient selection based on clinical need and current glycemic control